A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations – The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol

BACKGROUND: The most commonly applied treatment for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is a 5-day course of high-dose systemic corticosteroids. However, this treatment has not been shown to reduce mortality and can potentially have serious side effects. Recent rese...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Pulm Med
Main Authors: Sivapalan, Pradeesh, Moberg, Mia, Eklöf, Josefin, Janner, Julie, Vestbo, Jørgen, Laub, Rasmus Rude, Browatzki, Andrea, Armbruster, Karin, Wilcke, Jon Torgny, Seersholm, Niels, Weinreich, Ulla Møller, Titlestad, Ingrid Louise, Andreassen, Helle Frost, Ulrik, Charlotte Suppli, Bødtger, Uffe, Nielsen, Thyge Lynghøj, Hansen, Ejvind Frausing, Jensen, Jens Ulrik Stæhr
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5558695/
https://ncbi.nlm.nih.gov/pubmed/28810909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-017-0458-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados